Health, Beauty And Wellness News: GNC, Vitamin Shoppe, NPA, AHPA

Clock ticking on proxies for GNC's China proposal; 8 on Vitamin Shoppe Wellness Council; NPA lobby day has 200 meetings; and AHPA's Johnson presents at Canada's Natural Health Product Research conference.

[GNC Holdings Inc.] is reminding stockholders to vote in advance of its meeting that was delayed until May 9 to determine whether the firm will issue convertible preferred shares to Harbin Pharmaceutical Group Co. Ltd. in connection with the Chinese firm's offer of a $300m investment. The Pittsburgh-based manufacturer and retailer on May 2 said shareholders who have not voted probably do not have sufficient time to vote by mail before the deadline of 11:59 pm EST May 8. GNC suggests those shareholders vote online at a website that provides a platform for proxy votes or by phone. As it stated with its recent first-quarter results, it said more than 92% of the proxies received by the originally scheduled date for the special meeting, April 25, authorized a vote in favor of the proposal. However, those proxies were from owners of 36% of its shares, short of the necessary quorum of a majority of shares. Approval of the share issuance proposal requires the affirmative vote of a majority of shares present, either in person at the meeting in Pittsburgh or by proxy (Also see "GNC Digital Sales Hot But Shareholders Slow To Warm To China Expansion Deal" - HBW Insight, 27 April, 2018.)

Multi-channel nutritional products retailer and manufacturer [Vitamin Shoppe Inc.] rolls out its Wellness Council of eight health and fitness experts...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

Different Name, Same Contamination, Recall Problems For US Homeopathic Nasal Spray Firm

Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.

Kratom Industry Argues FDA Wants To Label All Products As Adverse Events Without Evidence

 

Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.

ACNU Switch And IND Exemption Final Rules Targeted For October In FDA Regulatory Goals

 

Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.

‘Inside Regulatory Affairs’ With Kenvue's Kevin Whelan

This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.

More from Geography

Perrigo Securities Class-Action Settlement Awards Attorneys’ Fees, Expenses Lower Than Requested

 

Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.

Over The Counter: Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland

 
• By 

In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry. 

US FDA Adcomm Reform Ideas: Neutral Facilitator As Chair, Public Hearing Lottery Process Tweaks

 
• By 

Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.